Aggregated News
Photo by Pepi Stojanovski on Unsplash
Four years after the FDA admonished stem cell clinic StemGenex for making dubious claims about its services in treating incurable diseases, and 3 years after the company first filed for bankruptcy, the clinic and its former CMO seem to have reached their final destination: a $3.65 million bill in a class action settlement.
Andre Lallande
Federal judge Anthony Battaglia in San Diego gave final approval to the deal in late February, with the insurance carriers for the now-dead clinic along with StemGenex’s former CMO and osteopath Andre Lallande footing the bill and paying 1,063 former clients. The insurance for the clinic will pay $1.15 million, and the insurer for Lallande, a rheumatologist, will pay $2.5 million.
“It’s been a rollercoaster ride watching this clinic for many years. From the start, what StemGenex was selling didn’t make much sense to me as a stem cell biologist. Now in the end, what’s surprising is that they got held accountable at all. Most stem cell clinics don’t,” Paul Knoepfler, a professor at UC Davis who wrote about...